NUVB insider transactions

SEC Form 4 filed by Director Vernon W Anthony

SEC Form 4 filed by Director Mashal Robert

SEC Form 4 filed by Director Falberg Kathryn E

SEC Form 4 filed by Director Blickenstaff Kim D

SEC Form 4 filed by Director Bazemore Robert B

SEC Form 4 filed by Director Cui Xiangmin

Amendment: SEC Form 4 filed by Director Cui Xiangmin

SEC Form 4 filed by Wentworth Kerry

SEC Form 4 filed by Liu Dongfang

SEC Form 4 filed by Wentworth Kerry

SEC Form 4 filed by CHIEF MEDICAL OFFICER Liu Dongfang

Officer Makunje Moses was granted 50,761 shares, increasing direct ownership by 292% to 68,137 units (SEC Form 4)

SEC Form 4 filed by CHIEF REGULATORY OFFICER Wentworth Kerry

SEC Form 4 filed by Chief Commercial Officer Sjogren Colleen

SEC Form 4 filed by Chief Financial Officer Sauvage Philippe

SEC Form 4 filed by CHIEF PEOPLE OFFICER Markel Stacy

SEC Form 4 filed by Director Cui Xiangmin

SEC Form 4 filed by CHIEF SCIENTIFIC OFFICER Hattersley Gary

SEC Form 4 filed by CHIEF TECHNICAL OPERATIONS Hanley David C.

SEC Form 4 filed by PRESIDENT AND CEO Hung David

CHIEF MEDICAL OFFICER Liu Dongfang exercised 150,000 shares at a strike of $2.93 and sold $1,173,255 worth of shares (150,000 units at $7.82) (SEC Form 4)

CHIEF MEDICAL OFFICER Liu Dongfang exercised 20,000 shares at a strike of $3.61 and sold $155,000 worth of shares (20,000 units at $7.75) (SEC Form 4)

CHIEF SCIENTIFIC OFFICER Hattersley Gary exercised 369,051 shares at a strike of $1.90 and sold $2,667,132 worth of shares (369,051 units at $7.23) (SEC Form 4)

CHIEF MEDICAL OFFICER Liu Dongfang exercised 20,000 shares at a strike of $1.87 and sold $140,074 worth of shares (20,000 units at $7.00) (SEC Form 4)

CHIEF TECHNICAL OPERATIONS Hanley David C. exercised 200,000 shares at a strike of $1.87 and sold $1,427,680 worth of shares (200,000 units at $7.14) (SEC Form 4)

CHIEF MEDICAL OFFICER Liu Dongfang exercised 30,000 shares at a strike of $1.87 and sold $148,028 worth of shares (30,000 units at $4.93), increasing direct ownership by 20% to 18,000 units (SEC Form 4)

CHIEF SCIENTIFIC OFFICER Hattersley Gary exercised 100,000 shares at a strike of $1.74 and sold $502,460 worth of shares (100,000 units at $5.02) (SEC Form 4)

SEC Form 4 filed by Director Mashal Robert

Chief Commercial Officer Sjogren Colleen bought $90,350 worth of shares (50,000 units at $1.81), increasing direct ownership by 161% to 81,000 units (SEC Form 4)

CHIEF PEOPLE OFFICER Markel Stacy bought $17,100 worth of shares (10,000 units at $1.71), increasing direct ownership by 51% to 29,591 units (SEC Form 4)

Chief Financial Officer Sauvage Philippe bought $13,216 worth of shares (7,300 units at $1.81), increasing direct ownership by 281% to 9,902 units (SEC Form 4)

PRESIDENT AND CEO Hung David bought $893,500 worth of shares (500,000 units at $1.79), increasing direct ownership by 0.85% to 59,281,054 units (SEC Form 4)

CHIEF REGULATORY OFFICER Wentworth Kerry bought $89,740 worth of shares (50,000 units at $1.79) (SEC Form 4)

SEC Form 4 filed by Director Blickenstaff Kim D

SEC Form 4 filed by Director Falberg Kathryn E

SEC Form 4 filed by Director Vernon W Anthony

SEC Form 4 filed by Director Bazemore Robert B

SEC Form 4 filed by Director Mashal Robert

CHIEF MEDICAL OFFICER Liu Dongfang exercised 20,000 shares at a strike of $1.94 and sold $50,024 worth of shares (20,000 units at $2.50) (SEC Form 4)

PRESIDENT AND CEO Hung David bought $820,220 worth of shares (500,000 units at $1.64), increasing direct ownership by 0.86% to 58,781,054 units (SEC Form 4)

Director Mashal Robert bought $166,985 worth of shares (100,000 units at $1.67) (SEC Form 4)

SEC Form 4 filed by CHIEF REGULATORY OFFICER Wentworth Kerry

SEC Form 4 filed by Chief Commercial Officer Sjogren Colleen

SEC Form 4 filed by Chief Financial Officer Sauvage Philippe

SEC Form 4 filed by CHIEF PEOPLE OFFICER Markel Stacy

SEC Form 4 filed by Officer Makunje Moses

SEC Form 4 filed by CHIEF MEDICAL OFFICER Liu Dongfang

SEC Form 4 filed by PRESIDENT AND CEO Hung David

SEC Form 4 filed by CHIEF SCIENTIFIC OFFICER Hattersley Gary

SEC Form 4 filed by CHIEF TECHNICAL OPERATIONS Hanley David C.

CEO, ANHEART THERAPEUTICS LTD. Wang Junyuan Jerry sold $162,883 worth of shares (56,361 units at $2.89), decreasing direct ownership by 1% to 3,866,228 units (SEC Form 4)

Director Mashal Robert bought $220,000 worth of shares (100,000 units at $2.20) (SEC Form 4)

SEC Form 4 filed by Chief Financial Officer Sauvage Philippe

SEC Form 3 filed by new insider Sauvage Philippe

SEC Form 4 filed by Director Vernon W Anthony

SEC Form 4 filed by Director Falberg Kathryn E

SEC Form 4 filed by Director Blickenstaff Kim D

SEC Form 4 filed by Director Bazemore Robert B

CEO, ANHEART THERAPEUTICS LTD. Wang Junyuan Jerry converted options into 4,239,300 shares, increasing direct ownership by 184% to 3,922,589 units (SEC Form 4)

Director Cui Xiangmin converted options into 19,004,200 shares (SEC Form 4)